Role of Nlrp3 Inflammasomes in Aggravation of Atherosclerosis and Xanthoma in Hyperlipidemic Mice Lacking Acyl Coa Cholesterol Acyltransferase 1 (acat1) in Bone Marrow

被引：0
|
作者：
Wakabayashi, Tetsuji
Takahashi, Manabu
Nagashima, Shuichi
Ebihara, Ken
Takahashi, Masafumi
Ishibashi, Shun
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Atherosclerosis; Inflammation and inflammatory markers; Cholesterol;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19830
引用
收藏
页数：2
相关论文
共 15 条
  • [1] Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow
    Wakabayashi, Tetsuji
    Takahashi, Manabu
    Yamamuro, Daisuke
    Karasawa, Tadayoshi
    Takei, Akihito
    Takei, Shoko
    Yamazaki, Hisataka
    Nagashima, Shuichi
    Ebihara, Ken
    Takahashi, Masafumi
    Ishibashi, Shun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (11) : 2576 - 2589
  • [2] Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1
    Accad, M
    Smith, SJ
    Newland, DL
    Sanan, DA
    King, LE
    Linton, MF
    Fazio, S
    Farese, RV
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (06): : 711 - 719
  • [3] A critical role for the histidine residues in the catalytic function of acyl-CoA:cholesterol acyltransferase catalysis:: Evidence for catalytic difference between ACAT1 and ACAT2
    An, Sojin
    Cho, Kyung-Hyun
    Lee, Woo Song
    Lee, He-Oh
    Paik, Young-Ki
    Jeong, Tae-Sook
    FEBS LETTERS, 2006, 580 (11): : 2741 - 2749
  • [4] Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression-An in vitro study
    Ayyagari, Vijayalakshmi N.
    Wang, Xinjia
    Diaz-Sylvester, Paula L.
    Groesch, Kathleen
    Brard, Laurent
    PLOS ONE, 2020, 15 (01):
  • [5] Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1
    Su, YR
    Dove, DE
    Major, AS
    Hasty, AH
    Boone, B
    Linton, MF
    Fazio, S
    CIRCULATION, 2005, 111 (18) : 2373 - 2381
  • [6] The Acyl-CoA:Cholesterol acyltransferase (ACAT)-inhibitor avasimibe reduces atherosclerosis independently of its lipid-lowering effect in apoE3-Leiden mice
    Delsing, BDJM
    Offerman, EH
    van Duyvenvoorde, W
    Van der Boom, H
    Havekes, M
    Princen, HMG
    CIRCULATION, 1999, 100 (18) : 613 - 613
  • [7] Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice
    Chandak, Prakash G.
    Obrowsky, Sascha
    Radovic, Branislav
    Doddapattar, Prakash
    Aflaki, Elma
    Kratzer, Adelheid
    Doshi, Lalit S.
    Povoden, Silvia
    Ahammer, Helmut
    Hoefler, Gerald
    Levak-Frank, Sanja
    Kratky, Dagmar
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2011, 1811 (12): : 1011 - 1020
  • [8] Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice
    Amengual, Jaume
    Ogando, Yoscar
    Nikain, Cyrus
    Quezada, Alexandra
    Qian, Kun
    Vaisar, Tomas
    Fisher, Edward A.
    MOLECULAR PHARMACOLOGY, 2021, 99 (03) : 175 - 183
  • [9] Role of adipocyte-derived factors in enhancing insulin signaling in skeletal muscle and white adipose tissue of mice lacking acyl CoA:diacylglycerol acyltransferase 1
    Chen, HC
    Rao, M
    Sajan, MP
    Standaert, M
    Kanoh, Y
    Miura, A
    Farese, RV
    Farese, RV
    DIABETES, 2004, 53 (06) : 1445 - 1451
  • [10] Intestinal cholesterol absorption is drastically reduced in mice deficient in both ATP-binding cassette transporter at (ABCA1) and acyl-CoA:cholesterol O-acyltransferase 2 (ACAT2)
    Temel, RE
    Lee, RG
    Kelly, KL
    Davis, MA
    Rudel, LL
    CIRCULATION, 2004, 110 (17) : 273 - 273
12